Anhui Fengyuan Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The report of Anhui Fengyuan Pharmaceutical Co Ltd employs intelligence from across the web as well as from available filings by Anhui Fengyuan Pharmaceutical Co Ltd. Check the end of the webpage for potential risks for Anhui Fengyuan Pharmaceutical Co Ltd based on sector, location and size. The article includes a questions and answers table about Anhui Fengyuan Pharmaceutical Co Ltd.
Anhui Fengyuan Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Anhui Fengyuan Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Anhui Fengyuan Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Anhui Fengyuan Pharmaceutical Co Ltd report the average age of the workforce?
Does Anhui Fengyuan Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Anhui Fengyuan Pharmaceutical Co Ltd offer flexible work?
Does Anhui Fengyuan Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Anhui Fengyuan Pharmaceutical Co Ltd conduct supply chain audits?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Anhui Fengyuan Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose water use targets?
Does Anhui Fengyuan Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Anhui Fengyuan Pharmaceutical Co Ltd have a product recall in the last two years?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Anhui Fengyuan Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Anhui Fengyuan Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose parental leave metrics?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Anhui Fengyuan Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Anhui Fengyuan Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Anhui Fengyuan Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose its waste policy?
Does Anhui Fengyuan Pharmaceutical Co Ltd report according to TCFD requirements?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose energy use targets?
Does Anhui Fengyuan Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Anhui Fengyuan Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Anhui Fengyuan Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biological pharmacy, chemical pharmacy, and traditional Chinese medicines primarily in China. It offers antipyretic-analgesic, cardiovascular, antibiotic, nervous system, anti-tumor, antiulcer, and hormone drugs, as well as nutraceuticals. The company also provides general medicines for vitamin and mineral deficiency; medicines for resisting parasitic diseases and microorganisms; coenzymes; and antiviral and uterine contractive medicines. In addition, it offers sedative-hypnotic drugs; drugs for curing mesenteric stress syndrome; drugs for lowering blood pressure; and drugs for curing benign prostatic hyperplasia. The company also exports its products to Europe, North America, Africa, Southeast Asia, and Central Asia. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.